Ford is expected to benefit from new U.S. tariff and emission rules, trimming costs and boosting its U.S.-built truck and vehicle margins.

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 5, 2024, and October 28, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 29, 2025.

Novo Nordisk A/S and Eli Lilly and Company have agreed to slash US prices for Ozempic, Wegovy, Mounjaro, and Zepbound, expanding Medicare/Medicaid access. NVO's stock has dropped sharply in 2025, but the new deal could boost long-term revenue by increasing drug accessibility and wiping out compounded competition. Despite price cuts, LLY's strong US manufacturing presence and blockbuster tirzepatide sales position it for continued growth and potential $1T market cap.

SAN FRANCISCO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Investors in Trex Company, Inc. (NYSE: TREX) saw the price of their shares crater as much as $14.88 (-31%) during intraday trading on November 5, 2025, after the building products company reported disappointing Q3 2025 financial results and dramatically reduced expected 2025 sales growth. The developments and severe market reaction has prompted national shareholders rights firm Hagens Berman to investigate whether Trex may have misled investors about adverse trends impacting its business and whether Trex sold more products to its customers than they needed.

When it comes to inflows, it seems like ETFs are content with beating themselves. After a record 2024 that saw inflows amass just under $1.14 trillion, ETFs did it again by edging past that level today.

ARC Resources Ltd. ( ARX:CA ) Q3 2025 Earnings Call November 7, 2025 10:00 AM EST Company Participants Taryn Bolder Terry Anderson - President, CEO & Director Kristen Bibby - Senior VP & CFO Armin Jahangiri - Senior VP & COO Conference Call Participants Michael Harvey - RBC Capital Markets, Research Division Kaleinoheaokealaula Akamine - BofA Securities, Research Division James Kubik - CIBC Capital Markets, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to ARC Resources Q3 2025 Earnings Conference Call.

BGSF, Inc. ( BGSF ) Q3 2025 Earnings Call November 7, 2025 9:00 AM EST Company Participants Keith Schroeder - Interim Co-CEO, CFO & Secretary Kelly Brown - Interim Co-Chief Executive Officer Conference Call Participants Sandra Martin - Three Part Advisors, LLC William Dezellem - Tieton Capital Management, LLC Presentation Operator Good morning, everyone. Welcome to the BGSF, Inc. Fiscal 2025 Third Quarter Financial Results Conference Call.

The Chemours Company ( CC ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants John McNulty - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Arun Viswanathan - RBC Capital Markets, Research Division Joshua Spector - UBS Investment Bank, Research Division Patrick Fischer - Goldman Sachs Group, Inc., Research Division Hassan Ahmed - Alembic Global Advisors …

Lilly's Mounjaro and Zepbound continue to power growth as new launches boost momentum amid rising obesity competition.

NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Minnesota on behalf of all persons or entities who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).

Affirm CEO Max Levchin told CNBC that some federal workers impacted by the government shutdown are losing interest in shopping. The federal funding lapse, which began Oct. 1, is the longest in U.S. history and has halted work across agencies.

JIANGYIN, China, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Li Bang International Corporation Inc. ("Li Bang International") and its subsidiaries (collectively, the "Company," "we," "us," "our company," or "Li Bang") (Nasdaq: LBGJ), a company engaged in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China, today announced its audited financial results for the fiscal year ended June 30, 2025.

ALAB's record Q3, soaring AI-driven sales and expanding partnerships highlight its strong growth momentum and profit scalability.

EVER, FOLD, LRCX and CBOE make the cut as top liquid stocks, with each boasting strong liquidity, growth attributes and operational efficiency.

Trade Desk Inc (NASDAQ:TTD) late Thursday reported third quarter 2025 revenue that rose 18% year over year to $739 million, surpassing the Wall Street forecast of $719 million. The company posted earnings per share for the period of $0.45, in line with the $0.44 consensus estimate, while Trade Desk's Q4 revenue guidance of $840 million also matched analyst expectations.

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 26, 2024 and September 17, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 26, 2025.

Innovative Industrial Properties offers a compelling 14% dividend yield, supported by a conservatively leveraged balance sheet and net lease model. IIPR faces ongoing tenant struggles and sector headwinds, but diversification into life sciences and a strong balance sheet provide resilience. Potential regulatory reform, such as cannabis rescheduling, could serve as a major catalyst, while the stock already prices in a lot of the worst-case scenarios.

Chorus Aviation Inc. ( CHR:CA ) Q3 2025 Earnings Call November 7, 2025 9:00 AM EST Company Participants Matt LaPierre Colin Copp - President, CEO & Director Gary Osborne - Chief Financial Officer Conference Call Participants Jasroop Bains - TD Cowen, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Chorus Aviation Inc. Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Friday, November 7, 2025.

Rand Capital ( RAND ) Q3 2025 Earnings Call November 7, 2025 10:00 AM EST Company Participants Daniel Penberthy - President & CEO Margaret Brechtel - Executive VP, Treasurer, CFO & Secretary Conference Call Participants Craig Mychajluk - Kei Advisors LLC Presentation Operator Greetings. Welcome to Rand Capital Corporation Third Quarter Fiscal Year 2025 Financial Results Conference Call.

FiscalNote Holdings, Inc. ( NOTE ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Bob Burrows Joshua Resnik - President, CEO & Director Jon Slabaugh - CFO, Chief Investment Officer & Senior VP of Corporate Development Conference Call Participants Mike Latimore - Northland Capital Markets, Research Division Ethan Widell - B. Riley Securities, Inc., Research Division Presentation Operator Good evening.